| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $54.6M | +69.0% |
| R&D Expense | $900K | -25.0% |
| SG&A Expense | $165.3M | -37.0% |
| Operating Income | -$172.1M | +35.8% |
| Pre-tax Income | -$154.6M | +44.1% |
| Income Tax | $2K | -94.9% |
| Net Income | -$154.6M | +44.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.6M | -99.0% |
| Accounts Receivable | $16.7M | +33.1% |
| Inventory | $2.1M | -21.8% |
| Current Assets | $38.3M | -87.2% |
| Total Assets | $341.3M | -28.0% |
| Current Liabilities | $102.4M | +6.6% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$117.2M | -25.6% |
| Capital Expenditures | $97.4M | +72.4% |
| Investing Cash Flow | -$102.9M | -79.6% |
| Financing Cash Flow | -$39.8M | -111.3% |
| Free Cash Flow | -$214.5M | -43.2% |
| Total Liabilities |
| $190.0M |
| -0.9% |
| Stockholders' Equity | $151.3M | -46.4% |